CAS No. : 93839-89-5
(Synonyms: Adenosine-5'-O-(3-thiotriphosphate) (tetralithium salt); Adenosine 5'-[γ-thio]triphosphate (tetralithium salt))
| Size | Price | Stock |
|---|---|---|
| 5mg | $198 | In-stock |
| 10mg | $338 | In-stock |
| 25mg | $720 | In-stock |
| 50mg | $1250 | In-stock |
| 100mg | $2150 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-108666 |
| M.Wt: | 546.98 |
| Formula: | C10H12Li4N5O12P3S |
| Purity: | >98 % |
| Solubility: | H2O : 75 mg/mL (ultrasonic);DMSO : 100 mg/mL (ultrasonic) |
ATPγS (tetralithium salt) is a P2Y11 receptor agonist, an antioxidant and a neuroprotective agent. ATPγS (tetralithium salt) can be used as a substrate for the nucleotide hydrolysis and RNA unwinding activities of eukaryotic translation initiation factor eIF4A. ATPγS (tetralithium salt) is active in ATP hydrolysis[1][2][3][4][5].
In Vitro:ATPγS (tetralithium salt) enhances intrinsic fluorescence and induces aggregation which increases the activity of spinach Rubisco activase[1].
ATPγS (50-100 μM final blood concentration) attenuates inflammatory response with decreased accumulation of cells (48%, P < 0.01) and proteins (57%, P < 0.01) in bronchoalveolar lavage and reduces neutrophil infiltration and extravasation of Evans blue albumin dye into lung tissue[3].
In Vivo:ATPγS (tetralithium salt, 50 μM final, intravenous) demonstrates preserved lung parenchymal architecture[3].
ATPγS results in a dose-dependent effect on EBA extravasation in LPS-treated mice[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.